Praxis Precision Medicines (PRAX) Preferred Stock Liabilities (2019)
Praxis Precision Medicines (PRAX) posted quarterly Preferred Stock Liabilities of $121.1 million for Q4 2019.
Praxis Precision Medicines (PRAX) Preferred Stock Liabilities (2019) Analysis & Trends
Praxis Precision Medicines' Preferred Stock Liabilities history runs 1 years deep, the most recent figure standing at $121.1 million for Q4 2019.
- In Q4 2019, Preferred Stock Liabilities changed N/A year-over-year to $121.1 million; the TTM figure through Dec 2019 stood at $121.1 million (changed N/A YoY), while the FY2019 annual figure was $121.1 million, changed N/A from the prior year.
- Preferred Stock Liabilities for Q4 2019 stood at $121.1 million.
- The five-year high for Preferred Stock Liabilities was $121.1 million in Q4 2019, with the low at $121.1 million in Q4 2019.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Preferred Stock Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.10 Bn | 131.24 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 84.66 Bn | 76.67 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 64.59 Bn | 59.40 Bn | 1.37 Bn | - |
| 4 | Moderna | 60.02 Bn | 54.88 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.64 Bn | 36.55 Bn | 1.53 Bn | - |
| 6 | Alnylam Pharmaceuticals | 31.90 Bn | 28.59 Bn | 992.69 Mn | - |
| 7 | Royalty Pharma | 27.38 Bn | 26.55 Bn | - | - |
| 8 | BioNTech SE | 27.36 Bn | 8.97 Bn | 668.28 Mn | - |
| 9 | Insmed | 26.66 Bn | 25.50 Bn | 358.27 Mn | - |
| 10 | Praxis Precision Medicines | 10.86 Bn | 10.10 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2019 | 121.12 Mn |